Higia Technologies revolutionizes early breast cancer detection through their product EVA. EVA is the first intelligent, portable, and non-invasive wearable designed to detect abnormalities in the thermal patterns of the breast, an indicator for the possible presence of breast cancer. EVA is equipped with sensors that collect thermal data of the surface of the breasts, with which the thermal patterns on the breast are mapped. This allows a professionalization of the auto-examination, complementing the conventional methods of diagnosis and screening. In essence, EVA provides women with personalized and actionable information for early breast cancer risk assessment, substantially increasing the probability of successful treatments.